Carefully Selected News and Features About Metastatic Breast Cancer Research
Metastatic Trial Talk empowers you with knowledge about the latest clinical trials, research, and treatment options for you to share and discuss with your doctor.
- LATEST UPDATES>September 2020
PD-L1 Biomarker for Immunotherapy
To qualify for Tecentriq®-based immunotherapy, the cancer must test positive for the PD-L1 protein. Learn what researchers have found about PD-L1 and other biomarkers to identify...
Read more
New Clinical Trials for Stage IV Breast Cancer (September 2020)
Click to find clinical trials that have been added to BreastCancerTrials.org and Metastatic Trial Search in August 2020, including trials for TNBC, HR positive and HER2 positive...
Read more
COVID-19 & Cancer
We have collected trusted information about COVID-19 that is especially relevant to people with breast cancer. This page will be updated regularly during the pandemic....
Read more
How Participants are Divided into Treatment Groups in Clinical Trials
Randomization is a part of clinical trial design that helps prevent accidental bias in the trial results. You might have specific feelings about participating in a randomized...
Read more
LBBC’s Conference on Metastatic Breast Cancer
In June, Living Beyond Breast Cancer (LBBC) held its Annual Conference on Metastatic Breast Cancer virtually. Read previews of the metastatic breast cancer research-based...
Read more
Metastatic Breast Cancer at a Young Age
Young women diagnosed with metastatic breast cancer often have unique experiences because of the career, family and social features of their age. Learn...
Read more
Depression & Metastatic Breast Cancer
Depression is common after a metastatic breast cancer diagnosis, whether caused by treatment or emotional stress. To learn more about depression after a metastatic diagnosis and...
Read moreSEARCH OUR SITE
for past articles or specific information.